Overview

Safety, Tolerability and Clinical Activity of ASM-024 in Stable Moderate Asthma

Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and clinical activity of ASM-024 in stable moderate asthma.
Phase:
Phase 2
Details
Lead Sponsor:
Asmacure Ltée